Frailty and cognitive impairment are not reasons to withhold anticoagulation in people with atrial fibrillation but screening could guide management
Journal of the American Geriatrics Society
Fecha de publicación: 24 de abril de 2021
Autores: Stephanie L. Harrison PhD, Asangaedem Akpan MPH FRCP, Gregory Y. H. Lip MD
Background: Oral anticoagulants (OACs) reduce the risk of stroke for people with atrial fibrillation (AF), and OACs are recommended in evidence-based guidelines for most people with AF.1 The net clinical benefit of OACs compared with no treatment or aspirin is clear for most people with AF, apart from those at lowest stroke risk.2 The common risk factors for incident AF are also risk factors for stroke and bleeding in AF.